Adaptimmune Therapeutics PLC

SUSQUEHANNA INTERNATIONAL GROUP, LLP ADAPY

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

308,065

Value ($000)

40

Weight

0.0%

2020 Q4 - 2025 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	40	0.0%	308,065	9/30/2025
2025 Q2	8/14/2025	10	0.0%	41,785	6/30/2025
2025 Q1	5/14/2025	3	0.0%	17,344	3/31/2025
2024 Q4	2/14/2025	16	0.0%	29,150	12/31/2024
2024 Q3	11/14/2024	180	0.0%	189,472	9/30/2024
2024 Q2	8/15/2024	236	0.0%	242,144	6/30/2024
2024 Q1	5/7/2024	89	0.0%	56,338	3/31/2024
2023 Q4	2/14/2024	45	0.0%	56,846	12/31/2023
2023 Q3	11/14/2023	130	0.0%	166,888	9/30/2023
2023 Q2	8/11/2023	168	0.0%	181,600	6/30/2023
2022 Q4	2/14/2023	41	0.0%	28,126	12/31/2022
2022 Q2	8/15/2022	229	0.0%	134,912	6/30/2022
2022 Q1	5/16/2022	165	0.0%	80,107	3/31/2022
2021 Q4	2/14/2022	420	0.0%	112,088	12/31/2021
2021 Q3	11/15/2021	1,155	0.0%	223,414	9/30/2021
2021 Q2	8/11/2021	469	0.0%	110,210	6/30/2021
2021 Q1	5/17/2021	271	0.0%	51,044	3/31/2021
2020 Q4	2/16/2021	796	0.0%	147,801	12/31/2020